Pretax income is the income that a company earns before paying income taxes. ICU Medical's pretax income for the
three
months ended in Dec. 2023 was $-37 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-78 Mil.
ICU Medical's pretax margin was -6.24%.
During the past 13 years, ICU Medical's highest Pretax Margin was 22.45%. The lowest was -5.02%. And the median was 8.37%.
ICU Medical Pre-Tax Income Historical Data
The historical data trend for ICU Medical's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ICU Medical's Pre-Tax Income
For the Medical Instruments & Supplies subindustry, ICU Medical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where ICU Medical's Pre-Tax Income falls into.
ICU Medical Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
ICU Medical's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (NAS:ICUI) Pre-Tax Income Explanation
ICU Medical's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, ICU Medical's highest Pretax Margin was 22.45%. The lowest was -5.02%. And the median was 8.37%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of ICU Medical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICUI has been successfully added to your 